文献速递淋巴瘤

4个自噬相关遗传变异被鉴定为慢性淋巴细胞白血病的风险因素

Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia.
PubMed 文献 · Blood Adv · 2025-01-01

研究纳入4个独立人群共5472例慢性淋巴细胞白血病(CLL)患者与726465名对照,分析55583个自噬相关单核苷酸多态性(SNP)与CLL风险的关联,并评估其对总生存、首次治疗时间、自噬流和免疫反应的影响。Meta分析首次发现CDKN2A(rs3731204)与BCL2(rs4940571、rs12457371、rs1026825)SNP与CLL风险显著相关,其中CDKN2A关联最强(P=1.57×10⁻¹²),并验证了FAS、BCL2、BAK1既往报道的关联。自噬变异与总生存或首次治疗时间无显著关联,提示这些变异驱动疾病发生而非进展。

要点

  • Meta分析首次发现CDKN2A(rs3731204)和BCL2(rs4940571、rs12457371、rs1026825)SNP与CLL风险显著相关。
  • CDKN2A关联最强(P=1.57×10⁻¹²),并验证FAS、BCL2、BAK1既往报道的关联(P=4.73×10⁻²¹至3.39×10⁻⁹)。
  • 自噬变异与总生存或首次治疗时间无显著关联,提示其驱动疾病发生而非进展。

核心结论

  • 研究鉴定出4个与CLL风险相关的新关联,并提示相关生物学通路可能影响CLL发生。
  • 自噬变异与总生存或首次治疗时间无显著关联,提示这些变异驱动疾病发生而非进展。

研究设计与样本

  • 研究分析55583个自噬相关SNP与CLL风险的关联,覆盖4个独立人群,共5472例CLL患者和726465名对照。
  • 研究同时评估这些SNP对总生存、首次治疗时间、自噬流和免疫反应的影响。

主要发现

  • Meta分析首次发现CDKN2A(rs3731204)与BCL2(rs4940571、rs12457371、rs1026825)SNP与CLL风险显著相关,其中CDKN2A关联最强(P=1.57×10⁻¹²)。
  • 验证了既往报道的FAS、BCL2和BAK1 SNP与CLL风险的关联(P=4.73×10⁻²¹至3.39×10⁻⁹)。
  • CDKN2Ars3731204与FASrs1926194 SNP与全血和/或淋巴细胞中CDKN2A与ACTA2信使RNA表达水平升高相关(P=5.1×10⁻⁷、P=1.58×10⁻²¹、P=7.8×10⁻⁴¹),但未观察到对自噬流的显著影响。
  • CDKN2A、BCL2和FAS SNP与多种T细胞亚群、细胞因子产生及干扰素γ、肿瘤坏死因子相关凋亡诱导配体、CD40、趋化因子配体20和白细胞介素-2受体β亚基蛋白的循环浓度相关(P≤.005)。
  • 自噬变异与总生存或首次治疗时间无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated the influence of 55 583 autophagy-related single-nucleotide polymorphisms (SNPs) on chronic lymphocytic leukemia (CLL) risk across 4 independent populations comprising 5472 CLL cases and 726 465 controls. We also examined their impact on overall survival (OS), time to first treatment (TTFT), autophagy flux, and immune responses. A meta-analysis of the 4 populations identified, to our knowledge, for the first time, significant associations between CDKN2A (rs3731204) and BCL2 (rs4940571, rs12457371, and rs1026825) SNPs and CLL risk, with CDKN2A showing the strongest association (P = 1.57 × 10-12). We also validated previously reported associations for FAS, BCL2, and BAK1 SNPs with CLL risk (P = 4.73 × 10-21 to 3.39 × 10-9). The CDKN2Ars3731204 and FASrs1926194 SNPs associated with increased CDKN2A and ACTA2 messenger RNA expression levels in the whole blood and/or lymphocytes (P = 5.1 × 10-7, P = 1.58 × 10-21, and P = 7.8 × 10-41), although no significant effect on autophagy flux was observed. However, associations were found between CDKN2A, BCL2, and FAS SNPs and various T-cell subsets, cytokine production, and circulating concentrations of interferon gamma, tumor necrosis factor-related apoptosis-inducing ligand, CD40, chemokine ligand 20, and interleukin-2 receptor subunit β proteins (P ≤ .005). No significant association was detected between autophagy variants and OS or TTFT, suggesting that these variants drive disease initiation rather than progression. In conclusion, this study identified 4 novel associations for CLL and provided insights into the biological pathways that influence CLL development.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cabrera-Serrano AJ, Sánchez-Maldonado JM, Rodríguez-Sevilla JJ, et al. Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia. Blood Adv. 2025. PMID: 40902075. doi:10.1182/bloodadvances.2025017345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。